PATHOPHYSIOLOGICAL MECHANISMS OF INFLAMMATION AND THEIR CLINICAL SIGNIFICANCE
DOI:
https://doi.org/10.5281/zenodo.20025958Keywords:
Inflammation; Pathophysiology; Cytokines; NF-κB; Inflammasome; Immune response; Chronic inflammation; Acute inflammation; Clinical significance; ImmunoregulationAbstract
Inflammation is a fundamental biological and pathophysiological process that plays a central role in the body’s defense against harmful stimuli, including infections, tissue injury, and toxic agents. This study aims to analyze the key mechanisms underlying inflammatory responses and to evaluate their clinical significance in the development and progression of diseases. The inflammatory process is initiated by the recognition of pathogen-associated and damage-associated molecular patterns through pattern recognition receptors, which activate intracellular signaling pathways such as nuclear factor kappa B (NF-κB) and inflammasome complexes. These pathways lead to the production and release of pro-inflammatory cytokines, including interleukin-1β, tumor necrosis factor-alpha, and interleukin-6, which regulate local and systemic immune responses.The findings of this study demonstrate that inflammation involves a coordinated interaction between vascular changes, leukocyte recruitment, and molecular mediators. Acute inflammation is characterized by rapid onset and effective elimination of harmful agents, whereas chronic inflammation is associated with prolonged immune activation, tissue damage, and fibrosis. Dysregulation of inflammatory pathways contributes significantly to the pathogenesis of various diseases, including cardiovascular disorders, metabolic syndromes, autoimmune conditions, and neurodegenerative diseases.Downloads
References
1.Abbas, A. K., Lichtman, A. H., & Pillai, S. (2021). Cellular and molecular immunology (10th ed.). Elsevier.
2.Kumar, V., Abbas, A. K., & Aster, J. C. (2020). Robbins and Cotran pathologic basis of disease (10th ed.). Elsevier.
3.Medzhitov, R. (2008). Origin and physiological roles of inflammation. Nature, 454(7203), 428–435. https://doi.org/10.1038/nature07201
4.Libby, P. (2002). Inflammation in atherosclerosis. Nature, 420(6917), 868–874. https://doi.org/10.1038/nature01323
5.Dinarello, C. A. (2011). Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood, 117(14), 3720–3732. https://doi.org/10.1182/blood-2010-07-273417
6.Chen, G. Y., & Nuñez, G. (2010). Sterile inflammation: Sensing and reacting to damage. Nature Reviews Immunology, 10(12), 826–837. https://doi.org/10.1038/nri2873
7.Lawrence, T. (2009). The nuclear factor NF-κB pathway in inflammation. Cold Spring Harbor Perspectives in Biology, 1(6), a001651. https://doi.org/10.1101/cshperspect.a001651
8.Guo, H., Callaway, J. B., & Ting, J. P. Y. (2015). Inflammasomes: Mechanism of action, role in disease, and therapeutics. Nature Medicine, 21(7), 677–687. https://doi.org/10.1038/nm.3893
9.Nathan, C., & Ding, A. (2010). Nonresolving inflammation. Cell, 140(6), 871–882. https://doi.org/10.1016/j.cell.2010.02.029
10.Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., & others. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine, 25(12), 1822–1832. https://doi.org/10.1038/s41591-019-0675-0
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India